Akoya Biosciences, Inc.
AKYA
$1.15
-$0.01-0.86%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.65M | -8.20M | -10.53M | -13.15M | -23.48M |
| Total Depreciation and Amortization | 1.80M | 1.85M | 1.83M | 1.93M | 2.05M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.49M | 2.86M | 1.84M | 3.97M | 8.82M |
| Change in Net Operating Assets | 3.15M | 506.00K | -2.39M | -3.79M | -8.22M |
| Cash from Operations | -7.21M | -2.98M | -9.26M | -11.04M | -20.82M |
| Capital Expenditure | -204.00K | -1.04M | -434.00K | -170.00K | -810.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 16.25M | 3.74M | 13.45M | 9.22M | -48.01M |
| Cash from Investing | 16.04M | 2.69M | 13.02M | 9.05M | -48.82M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -180.00K | -502.00K | -166.00K | -173.00K | -181.00K |
| Issuance of Common Stock | 7.00K | 16.00K | 16.00K | 23.00K | 36.00K |
| Repurchase of Common Stock | -77.00K | 0.00 | 0.00 | -65.00K | -149.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | -1.91M | -150.00K |
| Cash from Financing | -250.00K | -486.00K | -150.00K | -2.13M | -444.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.58M | -775.00K | 3.61M | -4.11M | -70.09M |